|
🐬
|
Dying with dementia: symptoms, treatment, and quality of life in the last week of life.
S. Hendriks,
M. Smalbrugge,
C. Hertogh,
J. T. van der Steen
|
7 |
2014 |
7
🐬
|
|
🐬
|
From admission to death: prevalence and course of pain, agitation, and shortness of breath, and treatment of these symptoms in nursing home residents with dementia.
S. Hendriks,
M. Smalbrugge,
F. Galindo‐Garre,
C. Hertogh,
J. T. van der Steen
|
6 |
2015 |
6
🐬
|
|
🦁
|
The impact of depression and anxiety on well being, disability and use of health care services in nursing home patients
M. Smalbrugge,
A. Pot,
Lineke Jongenelis,
C. Gundy,
A. Beekman,
J. Eefsting
|
6 |
2006 |
6
🦁
|
|
🐜
|
Coming to grips with challenging behavior: a cluster randomized controlled trial on the effects of a multidisciplinary care program for challenging behavior in dementia.
7 auth.
S. Zwijsen,
M. Smalbrugge,
J. Eefsting,
J. Twisk,
D. Gerritsen,
A. Pot,
...
C. Hertogh
|
6 |
2014 |
6
🐜
|
|
🦁
|
Pain among nursing home patients in the Netherlands: prevalence, course, clinical correlates, recognition and analgesic treatment – an observational cohort study
M. Smalbrugge,
Lineke Jongenelis,
A. Pot,
A. Beekman,
J. Eefsting
|
6 |
2007 |
6
🦁
|
|
🐜
|
A Review of Pain Prevalence in Alzheimer's, Vascular, Frontotemporal and Lewy Body Dementias
8 auth.
J. van Kooten,
T. Binnekade,
J. C. van der Wouden,
M. Stek,
E. Scherder,
B. Husebø,
...
M. Smalbrugge,
C. Hertogh
|
6 |
2016 |
6
🐜
|
|
🐬
|
A structural multidisciplinary approach to depression management in nursing-home residents: a multicentre, stepped-wedge cluster-randomised trial
R. Leontjevas,
D. Gerritsen,
M. Smalbrugge,
S. Teerenstra,
M. Vernooij-Dassen,
R. Koopmans
|
6 |
2013 |
6
🐬
|
|
🦁
|
Incidence and outcome of depressive symptoms in nursing home patients in the Netherlands.
M. Smalbrugge,
Lineke Jongenelis,
A. Pot,
J. Eefsting,
M. Ribbe,
A. Beekman
|
6 |
2006 |
6
🦁
|
|
🐬
|
Process evaluation to explore internal and external validity of the "Act in Case of Depression" care program in nursing homes.
R. Leontjevas,
D. Gerritsen,
R. Koopmans,
M. Smalbrugge,
M. Vernooij-Dassen
|
6 |
2012 |
6
🐬
|
|
🐜
|
Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study
8 auth.
K. van der spek,
D. Gerritsen,
M. Smalbrugge,
M. Nelissen-Vrancken,
R. Wetzels,
Claudia H W Smeets,
...
S. Zuidema,
R. Koopmans
|
6 |
2016 |
6
🐜
|
